[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Niewold, 2015 - Google Patents

Intestinal health biomarkers in vivo

Niewold, 2015

Document ID
13284323494686198035
Author
Niewold T
Publication year
Publication venue
Intestinal health

External Links

Snippet

There is a definite need for biomarkers for intestinal health in vivo, which can be determined in samples obtained in a non-invasive or minimally invasive way. In humans, there are approximately fifteen biomarkers suggested, and test and reagents are available, whereas …
Continue reading at brill.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/02—Investigating or analysing materials by specific methods not covered by the preceding groups food
    • G01N33/04—Investigating or analysing materials by specific methods not covered by the preceding groups food dairy products

Similar Documents

Publication Publication Date Title
Kaplan et al. Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets
Gilbert et al. Protein fermentation in the gut; implications for intestinal dysfunction in humans, pigs, and poultry
Oberli et al. High true ileal digestibility but not postprandial utilization of nitrogen from bovine meat protein in humans is moderately decreased by high-temperature, long-duration cooking
Verdier et al. Biliary mucosal barrier and microbiome
Eckersall Recent advances and future prospects for the use of acute phase proteins as markers of disease in animals
Peres et al. Biomarkers of acute kidney injury
Lewis The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease
ES2499025T3 (en) E. coli F18 + binding inhibitors
Niewold Intestinal health biomarkers in vivo
Søfteland et al. Pancreatic exocrine insufficiency in diabetes mellitus-prevalence and characteristics
Alford et al. Animal models of naturally occurring stone disease
JP2018536849A5 (en)
CN102341705B (en) Crohn's disease diagnostic reagent
Jiang et al. Intestinal proteomics in pig models of necrotising enterocolitis, short bowel syndrome and intrauterine growth restriction
Tóthová et al. Acute phase proteins in relation to various inflammatory diseases of calves
Collins Canine inflammatory bowel disease: current and prospective biomarkers for diagnosis and management
Mosberian-Tanha et al. Bacterial translocation and in vivo assessment of intestinal barrier permeability in rainbow trout (Oncorhynchus mykiss) with and without soyabean meal-induced inflammation
Yildiz et al. Evaluation of intestinal damage biomarkers in calves with atresia coli
Lecce Glucose milliequivalents eaten by the neonatal pig and cessation of intestinal absorption of large molecules (closure)
BR112020021550A2 (en) methods to determine a bird's intestinal health status
Miele et al. Altered intestinal permeability is predictive of early relapse in children with steroid‐responsive ulcerative colitis
Wijesiriwardana et al. A comparative analysis of gastrointestinal tract barrier function and immune markers in gilt vs. sow progeny at birth and weaning
Dahan et al. Circadian and postprandial variation in plasma citrulline concentration in healthy dogs
Socha-Banasiak et al. Intestinal fructose transporters GLUT5 and GLUT2 in children and adolescents with obesity and metabolic disorders
Ducatelle et al. Biomarkers for intestinal health